Suggestions
Dalia Mahmoud
Professional Background
Dalia Mahmoud is a highly accomplished professional in the pharmaceutical and healthcare sectors, recognized for her strategic leadership and extensive expertise in global market access and pricing strategies. Currently serving as the Vice President and Head of Global Market Access and Pricing at AbbVie, Dalia has been instrumental in shaping the company’s approach to market access and pricing, ensuring that innovative therapies reach patients globally. Her impressive career with AbbVie includes previous roles as the Vice President and Head of Global Market Access and Pricing for both the Immunology and Oncology divisions, where she led initiatives that optimized market strategies and enhanced patient access to critical therapies.
Before her tenure at AbbVie, Dalia made significant contributions to Celgene as the Executive Director - Head of Global Pricing and Market Access for Hematology Oncology. She played a pivotal role in developing pricing strategies that aligned with global healthcare standards, demonstrating her ability to navigate complex market demands effectively. Her expertise in market access was further refined during her tenure as the International Economic Strategy Leader at Roche, where she developed strategic frameworks for international markets.
Dalia's career began with roles that laid a strong foundation for her future successes. As a Senior Consultant at IMS Health, she provided in-depth insights and data-driven strategies for healthcare clients. Her early career also included a role as Manager of Client Strategies at Medco, where she was responsible for formulating client approaches that balanced efficiency with patient needs.
Her commitment to advancing healthcare continued at Pfizer, where she gained valuable experience as a Global Planning and Business Development Intern, and at Alk, A Trimble Company, where she contributed as a Product Manager. Each of these roles has equipped Dalia with a diverse skill set that she continues to leverage in her current position.
Education and Achievements
Dalia Mahmoud's educational journey is distinguished and reflects her commitment to excellence in both engineering and business. She graduated from Princeton University with a Bachelor of Science in Engineering and a Bachelor of Arts, showcasing her strong analytical skills and diverse knowledge base. Her pursuit of education continued at Columbia Business School, where she earned a Master of Business Administration in Healthcare Finance. This combination of technical and managerial education has afforded Dalia a unique perspective on the integration of engineering principles within the healthcare landscape.
Throughout her career, Dalia has earned a reputation for her strategic foresight and ability to foster collaboration among diverse teams. Her leadership style is characterized by a commitment to innovation and a focus on delivering value to patients and stakeholders alike. Dalia's significant contributions to the pharmaceutical industry have garnered recognition from her peers and colleagues, and she is frequently sought after for her insights into market access dynamics.
Achievements
Dalia Mahmoud’s career is marked by numerous achievements that underscore her expertise in the pharmaceutical industry. Some of her notable accomplishments include:
- Successfully leading market access initiatives that have resulted in improved patient access to groundbreaking therapies at AbbVie.
- Developing and implementing pricing strategies for complex therapeutic areas such as oncology and immunology, significantly enhancing the company’s competitive positioning in these markets.
- Spearheading international strategy for market access at Roche, ensuring alignment with evolving healthcare policies across multiple regions.
- Contributing to the strategic economic frameworks at Celgene, particularly in the hematology oncology segment, which have paved the way for innovative therapies to be accessible to diverse patient populations.
- Cultivating strong partnerships with healthcare stakeholders, including payers and regulatory bodies, to facilitate effective market strategies and pricing frameworks.
Dalia’s journey reflects her dedication to advancing healthcare through strategic leadership and innovative solutions. Her multi-faceted approach, backed by solid educational credentials and a wealth of experience, makes her a key figure in the field of global market access and pricing in pharmaceuticals.
